How to Access Affordable GLP-1 Weight Loss Drugs and Alternatives

Access to glucagon-like peptide-1 (GLP-1) weight loss medications has become increasingly restricted for millions of Americans as insurance providers tighten their coverage policies. In 2025, approximately six million people lost insurance coverage for these drugs due to policy reshuffling, and currently, fewer than 20 percent of employer health plans provide coverage for GLP-1s specifically for weight loss.

The financial barrier has driven many patients toward compounding pharmacies, which offer less expensive versions of tirzepatide and semaglutide. However, these alternatives have introduced new safety concerns and regulatory challenges, as the U.S. Food and Drug Administration (FDA) has ordered compounding pharmacies to stop manufacturing copies of these weight loss drugs.

The Risks of Compounded GLP-1s

Despite FDA bans, some compounded GLP-1 medications remain available. Some online pharmacies now market versions of semaglutide and tirzepatide in novel formulations, such as pills or combinations with other medications, to bypass restrictions.

Medical professionals warn that these compounded versions lack the rigorous clinical testing associated with FDA-approved drugs. Dr. Supriya Rao, an obesity physician and the director of medical weight loss at Lowell General Hospital in Lowell, Massachusetts, advises against them, noting that mixing active compounds without clinical data creates concerns regarding bioavailability, absorption, and patient safety.

Just because it’s cheaper doesn’t mean it’s better or safe. If it sounds too good to be true, it probably is.

Dr. Supriya Rao

Dr. Brynna Connor, a family medicine physician in private practice in Austin, Texas, emphasizes that while some sterile compounding pharmacies are reputable, the source of the medication is critical. She notes that the online market is often filled with counterfeits and illegal websites that sell these medications without requiring a prescription.

Direct-to-Consumer Pricing Options

To address high out-of-pocket costs, manufacturers have introduced lower-priced avenues for purchasing medications. Eli Lilly, the maker of tirzepatide (Zepbound and Mounjaro), offers these drugs for between $349 and $499 per month when purchased through Walmart or the company’s website. Lilly also sells its FDA-approved GLP-1 pill, Foundayo, via its direct-to-consumer site for $149 to $299 per month, depending on the dose.

Novo Nordisk, the manufacturer of semaglutide (Wegovy and Ozempic), provides weight loss and diabetes pills for $149 to $299 per month and injectables for $349 to $499 per month. These prices are available through the manufacturer’s website and partners such as Costco and WW.

In November 2025, both Eli Lilly and Novo Nordisk announced that even lower prices would be available in the coming years for medications purchased through a government-run website. Some of these lower-cost options may require the use of vials and syringes or pills rather than prefilled injector pens.

Navigating Insurance Denials

Patients facing coverage loss may be able to regain access through persistence and strategic medical documentation. Some patients have successfully appealed insurance denials by requesting new prior authorizations from their doctors.

Another strategy involves switching the diagnosis listed on the prescription. Because many GLP-1s are FDA-approved for conditions beyond weight loss, insurers may cover the drug if This proves prescribed for a different indication. Dr. Rao notes that these may include cardiovascular risk reduction, stroke prevention in specific populations, or metabolic dysfunction-associated steatohepatitis (MASH).

Dr. Brianna Johnson-Rabbett, an endocrinologist with Nebraska Medicine and a director of the American Board of Obesity Medicine, explains that Wegovy may be prescribed for those with obesity and established cardiovascular disease, while Zepbound may be indicated for those with obesity and moderate to severe obstructive sleep apnea. However, Dr. Johnson-Rabbett cautions that meeting FDA indications does not guarantee insurance coverage.

Prescription Alternatives and Surgery

For those who cannot access GLP-1s, healthcare providers may suggest older FDA-approved weight loss medications. While experts say these are generally not as effective as semaglutide or tirzepatide, they can assist with weight maintenance.

• Liraglutide (Saxenda): An older GLP-1 drug used for appetite suppression.
• Orlistat (Xenical, Alli): The only effective over-the-counter weight loss pill, which reduces fat absorption in the gut.
• Naltrexone-bupropion (Contrave): A combination of an antidepressant and opioid blocker often used for reward-based or emotional eating.
• Phentermine (Lomaira): A stimulant used to suppress appetite.
• Phentermine-topiramate (Qsymia): An oral medication combining phentermine with an anti-seizure drug.
• Metformin: A type 2 diabetes drug sometimes used off-label for prediabetes that can lead to modest weight loss.

For individuals with a body mass index (BMI) over 40, or over 35 with comorbidities, bariatric surgery is considered a safe and effective alternative. While the initial procedure can cost more than $10,000, it is often covered by insurance and may be more cost-effective long term than the indefinite use of GLP-1 medications.

Cautions Regarding Supplements and Dosing

Medical experts warn against over-the-counter supplements marketed as nature’s Ozempic, such as psyllium husk and berberine. Dr. Connor states there are no randomized clinical trials showing these supplements have a substantial effect on lasting weight loss.

There are no supplements, magic pills, or over-the-counter products that will reduce appetite and slow gastric emptying the way GLP-1s do. Don’t fall for anything that says otherwise

Dr. Supriya Rao

some users attempt to stretch their medication supply through microdosing or tapering. Dr. Johnson-Rabbett warns that these practices can lead to unintended dosing or contamination. While a 2024 analysis suggested that gradual tapering may help maintain body weight for months compared to stopping abruptly, doctors emphasize that any dosage adjustments must be done under professional medical supervision.